Abiopharma

Senti Bio to Present at the 2025 Synthetic Biology: Engineering, Evolution, & Design (SEED) Conference

Dario Unveils Groundbreaking GLP-1 and AI-Personalization Digital Health Findings

Journey Medical to Join Russell2000® and Russell 3000® Indexes

Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Netherton Syndrome

New Form 6-K - Sanofi Filed: 2025-06-24 AccNo: 0001193125-25-145347 Size: 155 KB

Tivic Health Announces 2025 Annual Meeting of Stockholders

Press Release: DiaMedica Therapeutics Announces Inclusion in the Russell 2000® and Russell 3000® Indexes

New Form 8-K - Journey Medical Corp Filed: 2025-06-24 AccNo: 0001104659-25-061956 Size: 223 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study Showing Enobosarm Significantly Reduced Body Weight Regain, Prevented Fat Regain, and Preserved Lean Mass After Semaglutide Discontinuation

Cellectar Biosciences Submits Phase 1b Clinical Trial Protocol to US Food and Drug Administration for CLR 125 to Treat Triple-Negative Breast Cancer (TNBC)

Journey Medical to Join Russell2000® and Russell 3000® Indexes

Baxter - Baxter Publishes Annual Corporate Responsibility Report, Demonstrating Ongoing Action to Make a Meaningful Difference Around the World

DiaMedica Therapeutics Announces Inclusion in the Russell 2000® and Russell 3000® Indexes

Baxter Publishes Annual Corporate Responsibility Report, Demonstrating Ongoing Action to Make a Meaningful Difference Around the World

SINTX Technologies Acquires SiNAPTIC Surgical Assets and IP to Expand into $1.3B Foot and Ankle Fusion Market